Related Experiment Videos
S100A8/A9 as a novel predictor for severe Mycoplasma pneumoniae pneumonia in children: A prospective observational
Zihui Liu1, Lihui Gao2, Yun Cui3
1Department of Critical Care Medicine, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Objective:
The calprotectin S100A8/A9 complex is released by stimulating neutrophils and monocytes, and inducing cytokine secretion, modulating the inflammatory response. The aim of present study was to investigate the role of S100A8/A9 in Severe Mycoplasma Pneumoniae Pneumonia (SMPP).
Study Design:
We conducted a prospective study on pediatric Mycoplasma Pneumoniae Pneumonia (MPP) from December 2023 to May 2024. Patients were categorized into the SMPP group and non-SMPP (Non-Mycoplasma Pneumoniae Pneumonia, NSMPP) group based on hospitalization. Matched subgroups were formed according to age, sex, co-infection.
Results:
A total of 132 patients were included. Serum S100A8/A9 levels in SMPP were significantly higher than those in NSMPP group (5.877 [3.202, 9.257] vs. 4.349 [2.495, 6.902] μg/mL, p = 0.049). Both C-Reactive Protein (CRP) and Lactate Dehydrogenase (LDH) levels were significantly elevated in SMPP compared to NSMPP groups (p = 0.009 and p = 0.036, respectively). Multivariate logistic regression analysis revealed that S100A8/A9 levels is a key predictor for SMPP. The Area Under the ROC Curve (AUC) for S100A8/A9 levels in predicting SMPP was 0.601 (95% CI: 0.512‒0.685). Post-matching, the AUC increased to 0.714 (95% CI: 0.549‒0.845), with an optimal cutoff value of S100A8/A9 at 4.067 μg/mL, a sensitivity of 75%, and a specificity of 70%. Additionally, the AUCs for CRP and LDH were 0.701 and 0.690, respectively. The combined variables of S100A8/A9 and CRP achieved an AUC of 0.742 (95% CI: 0.580‒0.867), showing a relative advantage over S100A8/A9 alone.
Conclusion:
Our findings indicate that serum S100A8/A9 is a potential adjunct biomarker for predicting severe Mycoplasma Pneumoniae Pneumonia (SMPP) in children. The conclusion is preliminary exploration and requires further validation in larger, multicenter prospective cohorts.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction